UK-based pharmaceutical giant AstraZeneca plans to build its largest drug manufacturing facility in Virginia, creating hundreds of new jobs as part of a $50 billion investment in the United States.

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and elsewhere, as well as R&D investment.

British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence in the company's largest market.

AstraZeneca's strategic $50B investment promises to revolutionize U.S. medicine production with advanced manufacturing and R&D facilities.

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump administration claiming some credit due to its tariff policy and

RICHMOND, Va. (WDBJ) - Astrazeneca is deciding where in Virginia it will establish its newest multi-billion dollar manufacturing facility. It’s the most money the company has ever invested in a single manufacturing site.

AstraZeneca, a pharmaceutical company, has announced its plans to bring a drug substance manufacturing facility to Virginia.

AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.

RICHMOND, Va. — Virginia Gov. Glenn Youngkin is speaking out about the recent announcement that the state is poised to become a global hub for biopharmaceutical manufacturing, with AstraZeneca. The company chose the commonwealth for its largest single manufacturing investment worldwide.